{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:21:35Z","timestamp":1792131695977,"version":"4.4.0"},"reference-count":101,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T00:00:00Z","timestamp":1627084800000},"content-version":"unspecified","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,7,6]]},"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Pharmacists are increasingly providing patient-focused services in community pharmacies, including in the area of sexual and reproductive health (SRH). Specific SRH areas have been the focus of research, but a broader perspective is needed to position pharmacists as SRH providers. This review explored research that described and evaluated professional pharmacy services across a broad range of SRH areas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Scoping review<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>Medline, EMBASE, CINAHL, Web of Science, Scopus and Cochrane Library (January 2007\u2013July 2020).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study selection<\/jats:title>\n                    <jats:p>Studies reporting on the description and evaluation of professional pharmacy SRH services provided by community pharmacists.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data extraction<\/jats:title>\n                    <jats:p>Two investigators screened studies for eligibility, and one investigator extracted the data. Data were analysed to primarily describe professional pharmacy services and intervention outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Forty-one studies were included. The main SRH areas and professional pharmacy services reported were sexually transmitted and bloodborne infections (63%) and screening (39%), respectively. Findings showed that pharmacists\u2019 delivery of SRH services was feasible, able to reach vulnerable and high-risk groups, and interventions were highly accepted and valued by users. However, integration into daily workflow, pharmacist remuneration, cost and reimbursement for patients, and policy regulations were some of the barriers identified to implementing SRH services. Studies were primarily in specific areas such as chlamydia screening or hormonal contraception prescribing, while studies in other areas (ie, medical abortion provision, long-acting reversible contraception prescribing and vaccine delivery in pregnant women) were lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This scoping review highlights the expansion of pharmacists\u2019 roles beyond traditional product-focused services in a number of SRH areas. Given the potential feasibility, users\u2019 acceptability and reach, pharmacists are ideally situated to enhance SRH care access. Future research describing implementation and evaluation of professional pharmacy services in all SRH areas is needed to promote access to these services through community pharmacies and position pharmacists as SRH providers worldwide.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-047034","type":"journal-article","created":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T12:46:34Z","timestamp":1627303594000},"page":"e047034","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":48,"title":["Sexual and reproductive health services provided by community pharmacists: a scoping review"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8463-6473","authenticated-orcid":false,"given":"Javiera","family":"Navarrete","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5154-7490","authenticated-orcid":false,"given":"Nese","family":"Yuksel","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3221-4444","authenticated-orcid":false,"given":"Theresa J","family":"Schindel","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2476-9802","authenticated-orcid":false,"given":"Christine A","family":"Hughes","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,7,26]]},"reference":[{"key":"2025121411152501000_11.7.e047034.1","unstructured":"Galati JA . Onward to 2030: sexual and reproductive health and rights in the context of the sustainable development goals. In: Guttmacher Policy Review. 18. Washington, DC: Guttmacher Institute, 2015. https:\/\/www.guttmacher.org\/sites\/default\/files\/article_files\/gpr1807715.pdf"},{"key":"2025121411152501000_11.7.e047034.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30293-9"},{"key":"2025121411152501000_11.7.e047034.3","doi-asserted-by":"crossref","DOI":"10.3390\/pharmacy8030140","article-title":"The role of hospital and community pharmacists in the management of COVID-19: towards an expanded definition of the roles, responsibilities, and duties of the pharmacist","volume":"8","author":"Bragazzi","year":"2020","journal-title":"Pharmacy"},{"key":"2025121411152501000_11.7.e047034.4","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17020536","article-title":"The community pharmacist: perceived barriers and patient-centered care communication","volume":"17","author":"Ilardo","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"2025121411152501000_11.7.e047034.5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/IJGM.S99540","article-title":"Pharmacist-Led minor ailment programs: a Canadian perspective","volume":"9","author":"Taylor","year":"2016","journal-title":"Int J Gen Med"},{"key":"2025121411152501000_11.7.e047034.6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40545-018-0149-7","article-title":"The impact of clinical services provided by community pharmacies on the Australian healthcare system: a review of the literature","volume":"11","author":"Buss","year":"2018","journal-title":"J Pharm Policy Pract"},{"key":"2025121411152501000_11.7.e047034.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1759-8893.2011.00074.x"},{"key":"2025121411152501000_11.7.e047034.8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/ijpp.12611","article-title":"A global survey on trends in advanced practice and specialisation in the pharmacy workforce","volume":"28","author":"Bates","year":"2020","journal-title":"Int J Pharm Pract"},{"key":"2025121411152501000_11.7.e047034.9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/pharmacy7030106","article-title":"Community-based pharmacy practice innovation and the role of the community-based pharmacist practitioner in the United States","volume":"7","author":"Goode","year":"2019","journal-title":"Pharmacy"},{"key":"2025121411152501000_11.7.e047034.10","doi-asserted-by":"publisher","DOI":"10.1136\/jech.2006.055442"},{"key":"2025121411152501000_11.7.e047034.11","unstructured":"World Health Organization . The legal and regulatory framework for community pharmacies in the WHO European region. Denmark, 2019. Available: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/326394\/9789289054249-eng.pdf"},{"key":"2025121411152501000_11.7.e047034.12","unstructured":"International pharmaceutical Federation (FIP) . Advanced practice and specialization in pharmacy: global report 2015. The Hague 2015 https:\/\/www.fip.org\/file\/1397"},{"key":"2025121411152501000_11.7.e047034.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2013.02.005"},{"key":"2025121411152501000_11.7.e047034.14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.contraception.2007.11.010","article-title":"The continuum of care: a case for pharmacists as key members of the reproductive health care team","volume":"77","author":"Maderas","year":"2008","journal-title":"Contraception"},{"key":"2025121411152501000_11.7.e047034.15","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/pharmacy8040236","article-title":"Expanding pharmacy capacity for patient-centered reproductive health services","volume":"8","author":"Pfaff","year":"2020","journal-title":"Pharmacy"},{"key":"2025121411152501000_11.7.e047034.16","article-title":"Primary health care policy and vision for community pharmacy and pharmacists in Portugal","volume":"18","author":"Ribeiro","year":"2020","journal-title":"Pharm Pract"},{"key":"2025121411152501000_11.7.e047034.17","article-title":"Primary health care policy and vision for community pharmacy and pharmacists in Indonesia","volume":"18","author":"Hermansyah","year":"2020","journal-title":"Pharm Pract"},{"key":"2025121411152501000_11.7.e047034.18","article-title":"Primary health care policy and vision for community pharmacy and pharmacists in England","volume":"18","author":"Anderson","year":"2020","journal-title":"Pharm Pract"},{"key":"2025121411152501000_11.7.e047034.19","first-page":"99","article-title":"Role of the community pharmacist in emergency contraception counseling and delivery in the United States: current trends and future prospects","volume":"6","author":"Rafie","year":"2017","journal-title":"Integr Pharm Res Pract"},{"key":"2025121411152501000_11.7.e047034.20","unstructured":"Department of health and social care . The pharmacy offer for sexual health, reproductive health and HIV. In: . 25. London: Public Health England, 2019."},{"key":"2025121411152501000_11.7.e047034.21","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-010-9458-x"},{"key":"2025121411152501000_11.7.e047034.22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/humrep\/dei287","article-title":"Community pharmacy supply of emergency hormonal contraception: a structured literature review of international evidence","volume":"21","author":"Anderson","year":"2006","journal-title":"Hum Reprod"},{"key":"2025121411152501000_11.7.e047034.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.whi.2016.08.003"},{"key":"2025121411152501000_11.7.e047034.24","doi-asserted-by":"publisher","DOI":"10.1159\/000444686"},{"key":"2025121411152501000_11.7.e047034.25","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/1715163515611144","article-title":"Canadian \"minor ailments\" programs: unanswered questions","volume":"148","author":"Lee","year":"2015","journal-title":"Can Pharm J"},{"key":"2025121411152501000_11.7.e047034.26","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/jac5.1245","article-title":"Current status of prescriptive authority by pharmacists in the United States","volume":"3","author":"Sachdev","year":"2020","journal-title":"J Am Coll Clin Pharm"},{"key":"2025121411152501000_11.7.e047034.27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.japh.2018.07.002","article-title":"Remunerated patient care services and injections by pharmacists: an international update","volume":"59","author":"Houle","year":"2019","journal-title":"J Am Pharm Assoc"},{"key":"2025121411152501000_11.7.e047034.28","doi-asserted-by":"publisher","DOI":"10.1057\/jphp.2012.11"},{"key":"2025121411152501000_11.7.e047034.29","doi-asserted-by":"publisher","DOI":"10.1331\/JAPhA.2010.09039"},{"key":"2025121411152501000_11.7.e047034.30","first-page":"67","article-title":"Pharmacist-Led screening in sexually transmitted infections: current perspectives","volume":"7","author":"Wood","year":"2018","journal-title":"Integr Pharm Res Pract"},{"key":"2025121411152501000_11.7.e047034.31","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.contraception.2020.10.012","article-title":"Patient and pharmacist perspectives on pharmacist-prescribed contraception: a systematic review","volume":"103","author":"Eckhaus","year":"2021","journal-title":"Contraception"},{"key":"2025121411152501000_11.7.e047034.32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/1757913919867356","article-title":"Emergency hormonal contraceptive service provision via community pharmacies in the UK: a systematic review of pharmacists' and young women's views, perspectives and experiences","volume":"140","author":"Chirewa","year":"2020","journal-title":"Perspect Public Health"},{"key":"2025121411152501000_11.7.e047034.33","doi-asserted-by":"publisher","DOI":"10.1783\/147118908784734747"},{"key":"2025121411152501000_11.7.e047034.34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1759-8893.2011.00050.x","article-title":"Sexual\/reproductive health and the pharmacist: what is known and what is needed?","volume":"2","author":"Chin","year":"2011","journal-title":"J Pharm Health Serv Res"},{"key":"2025121411152501000_11.7.e047034.35","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.contraception.2016.12.002","article-title":"Pharmacy provision of sexual and reproductive health commodities to young people: a systematic literature review and synthesis of the evidence","volume":"95","author":"Gonsalves","year":"2017","journal-title":"Contraception"},{"key":"2025121411152501000_11.7.e047034.36","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2019-054096"},{"key":"2025121411152501000_11.7.e047034.37","unstructured":"International Pharmaceutical Federation (FIP) . Call to action to support pharmacists and pharmacy workers on the coronavirus COVID-19 frontline, 2020. Available: https:\/\/www.fip.org\/files\/content\/publications\/2020\/FIP-call-to-action-to-support-pharmacists-and-pharmacy-workers-on-the-coronavirus-COVID-19-frontline.pdf"},{"key":"2025121411152501000_11.7.e047034.38","doi-asserted-by":"publisher","DOI":"10.1080\/1364557032000119616"},{"key":"2025121411152501000_11.7.e047034.39","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-5-69"},{"key":"2025121411152501000_11.7.e047034.40","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850"},{"key":"2025121411152501000_11.7.e047034.41","doi-asserted-by":"crossref","unstructured":"Hamid H , Masood RA , Tariq H , et al . Current pharmacy practices in low- and middle-income countries; recommendations in response to the COVID-19 pandemic. Drugs Ther Perspect 2020:1\u20133.doi:10.1007\/s40267-020-00745-7","DOI":"10.1007\/s40267-020-00745-7"},{"key":"2025121411152501000_11.7.e047034.42","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6874-9-7"},{"key":"2025121411152501000_11.7.e047034.43","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2011-050357"},{"key":"2025121411152501000_11.7.e047034.44","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003338"},{"key":"2025121411152501000_11.7.e047034.45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1071\/PY12135","article-title":"'Catching Chlamydia': combining cash incentives and community pharmacy access for increased Chlamydia screening, the view of young people","volume":"21","author":"Parker","year":"2015","journal-title":"Aust J Prim Health"},{"key":"2025121411152501000_11.7.e047034.46","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-010-9460-3"},{"key":"2025121411152501000_11.7.e047034.47","doi-asserted-by":"publisher","DOI":"10.1136\/qshc.2006.020883"},{"key":"2025121411152501000_11.7.e047034.48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2010.02573.x"},{"key":"2025121411152501000_11.7.e047034.49","doi-asserted-by":"publisher","DOI":"10.1177\/0956462416633969"},{"key":"2025121411152501000_11.7.e047034.50","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/OLQ.0000000000001163","article-title":"Do prescriptions for expedited partner therapy for Chlamydia get filled? findings from a multi-jurisdictional evaluation, United States, 2017-2019","volume":"47","author":"Slutsker","year":"2020","journal-title":"Sex Transm Dis"},{"key":"2025121411152501000_11.7.e047034.51","doi-asserted-by":"crossref","first-page":"ofz365","DOI":"10.1093\/ofid\/ofz365","article-title":"Acceptability and feasibility of a pharmacist-led HIV pre-exposure prophylaxis (PreP) program in the midwestern United States","volume":"6","author":"Havens","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2025121411152501000_11.7.e047034.52","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1177\/0033354918801026","article-title":"The \"no wrong door\" approach to HIV testing: Results from a statewide retail pharmacy-based HIV testing program in Virginia, 2014-2016","volume":"133","author":"Collins","year":"2018","journal-title":"Public Health Rep"},{"key":"2025121411152501000_11.7.e047034.53","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/00333549161310S116","article-title":"Pharmacy intervention to improve HIV testing uptake using a comprehensive health screening approach","volume":"131 Suppl 1","author":"Crawford","year":"2016","journal-title":"Public Health Rep"},{"key":"2025121411152501000_11.7.e047034.54","doi-asserted-by":"publisher","DOI":"10.1331\/JAPhA.2015.14070"},{"key":"2025121411152501000_11.7.e047034.55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134631","article-title":"Widening the access to HIV testing: the contribution of three in-pharmacy testing programmes in Spain","volume":"10","author":"Fern\u00e1ndez-Balbuena","year":"2015","journal-title":"PLoS One"},{"key":"2025121411152501000_11.7.e047034.56","doi-asserted-by":"publisher","DOI":"10.1331\/JAPhA.2014.14045"},{"key":"2025121411152501000_11.7.e047034.57","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-020-08719-0","article-title":"Expanding access to HIV testing through Canadian community pharmacies: findings from the approach study","volume":"20","author":"Kelly","year":"2020","journal-title":"BMC Public Health"},{"key":"2025121411152501000_11.7.e047034.58","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1080\/21645515.2019.1602433","article-title":"Implementing pharmacy-located HPV vaccination: findings from pilot projects in five U.S. states","volume":"15","author":"Calo","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"2025121411152501000_11.7.e047034.59","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/pharmacy7030091","article-title":"Feasibility of a coordinated human papillomavirus (HPV) vaccination program between a medical clinic and a community pharmacy","volume":"7","author":"Doucette","year":"2019","journal-title":"Pharmacy"},{"key":"2025121411152501000_11.7.e047034.60","doi-asserted-by":"crossref","DOI":"10.1177\/2050312116682128","article-title":"A multimodal approach to improving human papillomavirus vaccination in a community pharmacy setting","volume":"4","author":"Hohmeier","year":"2016","journal-title":"SAGE Open Med"},{"key":"2025121411152501000_11.7.e047034.61","first-page":"67","article-title":"Impact of a pharmacist conducted educational program on human papilloma virus vaccination rates in a low socioeconomic population in the city of Lares, PR","volume":"36","author":"Jim\u00e9nez-Qui\u00f1ones","year":"2017","journal-title":"P R Health Sci J"},{"key":"2025121411152501000_11.7.e047034.62","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1331\/JAPhA.2014.13222","article-title":"Development of a community pharmacy human papillomavirus vaccine program for underinsured university students along the United States\/Mexico border","volume":"54","author":"Navarrete","year":"2014","journal-title":"J Am Pharm Assoc"},{"key":"2025121411152501000_11.7.e047034.63","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/jvh.13207","article-title":"The testing of people with any risk factor for hepatitis C in community pharmacies is cost-effective","volume":"27","author":"Buchanan","year":"2020","journal-title":"J Viral Hepat"},{"key":"2025121411152501000_11.7.e047034.64","doi-asserted-by":"crossref","unstructured":"Buchanan R , Hassan-Hicks P , Noble K , et al . Integrating community pharmacy testing for hepatitis C with specialist care. Pharm J 2016;8.doi:10.1211\/PJ.2016.20201549","DOI":"10.1211\/PJ.2016.20201549"},{"key":"2025121411152501000_11.7.e047034.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2017.04.463"},{"key":"2025121411152501000_11.7.e047034.66","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2016-100776"},{"key":"2025121411152501000_11.7.e047034.67","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S2468-1253(20)30120-5","article-title":"Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial","volume":"5","author":"Radley","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025121411152501000_11.7.e047034.68","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/AOG.0000000000003286","article-title":"Pharmacist provision of hormonal contraception in the Oregon Medicaid population","volume":"133","author":"Anderson","year":"2019","journal-title":"Obstet Gynecol"},{"key":"2025121411152501000_11.7.e047034.69","doi-asserted-by":"publisher","DOI":"10.1331\/JAPhA.2008.07138"},{"key":"2025121411152501000_11.7.e047034.70","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.contraception.2018.12.002","article-title":"Characterizing pharmacist-prescribed hormonal contraception services and users in California and Oregon pharmacies","volume":"99","author":"Lu","year":"2019","journal-title":"Contraception"},{"key":"2025121411152501000_11.7.e047034.71","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.contraception.2020.05.016","article-title":"Reasons for and experience in obtaining pharmacist prescribed contraception","volume":"102","author":"Rodriguez","year":"2020","journal-title":"Contraception"},{"key":"2025121411152501000_11.7.e047034.72","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.5252","article-title":"Association of pharmacist prescription with dispensed duration of hormonal contraception","volume":"3","author":"Rodriguez","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025121411152501000_11.7.e047034.73","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.contraception.2020.07.001","article-title":"Pharmacist prescription and access to hormonal contraception for Medicaid-insured women in Oregon","volume":"102","author":"Gibbs","year":"2020","journal-title":"Contraception"},{"key":"2025121411152501000_11.7.e047034.74","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/13625187.2017.1357808","article-title":"The feasibility of contraceptive injections at the community pharmacy","volume":"22","author":"Heller","year":"2017","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"2025121411152501000_11.7.e047034.75","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1331\/JAPhA.2007.06112","article-title":"Pharmacy and clinic partnerships to expand access to injectable contraception","volume":"47","author":"Monastersky Maderas","year":"2007","journal-title":"J Am Pharm Assoc"},{"key":"2025121411152501000_11.7.e047034.76","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.contraception.2010.01.013","article-title":"Pharmacist-administered subcutaneous depot medroxyprogesterone acetate: a pilot randomized controlled trial","volume":"82","author":"Picardo","year":"2010","journal-title":"Contraception"},{"key":"2025121411152501000_11.7.e047034.77","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsrh-2018-200236"},{"key":"2025121411152501000_11.7.e047034.78","doi-asserted-by":"crossref","unstructured":"Turnbull G , Scott RH , Mann S . Accessing emergency contraception pills from pharmacies: the experience of young women in London. BMJ Sex Reprod Health 2020:23.doi:10.1136\/bmjsrh-2019-200339","DOI":"10.1136\/bmjsrh-2019-200339"},{"key":"2025121411152501000_11.7.e047034.79","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2014.05.004"},{"key":"2025121411152501000_11.7.e047034.80","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.japh.2016.09.001","article-title":"Use of targeted medication reviews to deliver preconception care: a demonstration project","volume":"57","author":"DiPietro Mager","year":"2017","journal-title":"J Am Pharm Assoc"},{"key":"2025121411152501000_11.7.e047034.81","doi-asserted-by":"crossref","first-page":"e0219424","DOI":"10.1371\/journal.pone.0219424","article-title":"Community pharmacist counseling in early pregnancy-results from the SafeStart feasibility study","volume":"14","author":"Truong","year":"2019","journal-title":"PLoS One"},{"key":"2025121411152501000_11.7.e047034.82","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1111\/jsm.12238","article-title":"Community pharmacy detection of erectile dysfunction in men with risk factors or who seek treatment or advice but lack a valid prescription","volume":"10","author":"Martin Morales","year":"2013","journal-title":"J Sex Med"},{"key":"2025121411152501000_11.7.e047034.83","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2019-054045"},{"key":"2025121411152501000_11.7.e047034.84","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2012.11.003"},{"key":"2025121411152501000_11.7.e047034.85","first-page":"1","article-title":"Reproductive health under COVID-19 - challenges of responding in a global crisis","volume":"28","author":"Church","year":"2020","journal-title":"Sex Reprod Health Matters"},{"key":"2025121411152501000_11.7.e047034.86","doi-asserted-by":"crossref","first-page":"1746065","DOI":"10.1080\/26410397.2020.1746065","article-title":"COVID-19: what implications for sexual and reproductive health and rights globally?","volume":"28","author":"Hussein","year":"2020","journal-title":"Sex Reprod Health Matters"},{"key":"2025121411152501000_11.7.e047034.87","doi-asserted-by":"crossref","DOI":"10.1186\/s12978-020-0900-9","article-title":"Sexual and reproductive health (SRH): a key issue in the emergency response to the coronavirus disease (COVID- 19) outbreak","volume":"17","author":"Tang","year":"2020","journal-title":"Reprod Health"},{"key":"2025121411152501000_11.7.e047034.88","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1363\/psrh.12150","article-title":"COVID-19 and immigrants' access to sexual and reproductive health services in the United States","volume":"52","author":"Desai","year":"2020","journal-title":"Perspect Sex Reprod Health"},{"key":"2025121411152501000_11.7.e047034.89","doi-asserted-by":"publisher","DOI":"10.1363\/psrh.12151"},{"key":"2025121411152501000_11.7.e047034.90","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.japh.2019.05.015","article-title":"Pharmacist-prescribed hormonal contraception: a review of the current landscape","volume":"59","author":"Tak","year":"2019","journal-title":"J Am Pharm Assoc"},{"key":"2025121411152501000_11.7.e047034.91","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/pharmacy8020105","article-title":"Emergency contraception access and counseling in urban pharmacies: a comparison between states with and without pharmacist prescribing","volume":"8","author":"Stone","year":"2020","journal-title":"Pharmacy"},{"key":"2025121411152501000_11.7.e047034.92","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1139\/facets-2017-0024","article-title":"The not so over-the-counter status of emergency contraception in Ontario: a mixed methods study with pharmacists","volume":"2","author":"Chaumont","year":"2017","journal-title":"FACETS"},{"key":"2025121411152501000_11.7.e047034.93","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jogc.2017.04.042","article-title":"Beyond plan B: a qualitative study of Canadian pharmacists' emergency contraception counselling practices","volume":"39","author":"Wong","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"key":"2025121411152501000_11.7.e047034.94","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.sapharm.2018.07.013","article-title":"Analytical quality and effectiveness of point-of-care testing in community pharmacies: a systematic literature review","volume":"15","author":"Buss","year":"2019","journal-title":"Res Social Adm Pharm"},{"key":"2025121411152501000_11.7.e047034.95","doi-asserted-by":"publisher","DOI":"10.1586\/14737159.2015.1116388"},{"key":"2025121411152501000_11.7.e047034.96","doi-asserted-by":"publisher","DOI":"10.5688\/ajpe808129"},{"key":"2025121411152501000_11.7.e047034.97","unstructured":"Black A , Costescu D , Guilbert E . Contraception consensus: updated guidance during pandemics and periods of social disruption, 2020. Available: https:\/\/sogc.org\/common\/Uploaded%20files\/2020-04%20Contraception%20Consensus%20-%20Final%20Submitted.pdf"},{"key":"2025121411152501000_11.7.e047034.98","unstructured":"Action Canada for Sexual Health & Rights . Prioritizing the neglected areas of SRHR in Canada\u2019s global COVID-19 response, 2020. Available: https:\/\/www.actioncanadashr.org\/resources\/policy-briefs-submissions\/2020-04-15-prioritizing-neglected-areas-srhr-canadas-global-covid-19-response [Accessed 11 Oct 2020]."},{"key":"2025121411152501000_11.7.e047034.99","unstructured":"Costescu D , Guilbert E , Wagner M-S , et al . Induced abortion: updated guidance during pandemics and periods of social disruption, 2020. Available: https:\/\/sogc.org\/common\/Uploaded%20files\/Induced%20Abortion%20-%20Pandemic%20Guidance%20-%20FINAL.PDF"},{"key":"2025121411152501000_11.7.e047034.100","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.06.006"},{"key":"2025121411152501000_11.7.e047034.101","doi-asserted-by":"crossref","DOI":"10.5688\/ajpe8176181","article-title":"Discrepancies in lesbian, gay, bisexual, and transgender patient care and how pharmacists can support an evolved practice","volume":"81","author":"Maxwell","year":"2017","journal-title":"Am J Pharm Educ"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-047034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T19:15:39Z","timestamp":1765739739000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-047034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":101,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,26]]},"published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1136\/bmjopen-2020-047034"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-047034","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}